CD Formulation's Zeta potential analysis platform offers highly accurate measurements and detailed charge characterization data for a diverse array of nanocarriers. Our platform enables researchers to evaluate nanoparticle stability, optimize formulations, and analyze interactions with biological systems using advanced technologies.
Zeta potential measurement is a crucial tool for evaluating the surface electrical properties of particles in nucleic acid formulations. It allows for the determination of the solid-liquid interfacial electrical characteristics of particulate matter in a dispersed system, which is essential for understanding its stability and surface properties. A higher zeta potential indicates a greater repulsive force between particles, reducing the likelihood of agglomeration and thereby enhancing the stability of the system. Consequently, the stability of the system can be effectively assessed or predicted based on the magnitude of the zeta potential.
Fig.1 Schematic diagram of zeta potential. (CD Formulation)
Methods | Descriptions | Applications |
---|---|---|
Electrophoretic Light Scattering (ELS) Method | ELS is a technique that applies voltage to an electrophoretic cell, causing charged colloidal particles to migrate in response to an electric field. Laser Doppler velocimetry is then employed to measure the migration rate of these colloidal particles. | This method is widely utilized for analyzing various types of nucleic acid drug formulations. |
Electroosmosis (EO) Method | Electroosmosis is achieved by applying an electric field to a capillary tube filled with the solution to be analyzed, which causes the liquid to migrate relative to the inner wall of the tube. By measuring this migration, the zeta potential can be indirectly inferred. | This method is commonly employed for zeta potential measurements at solid-liquid interfaces and is particularly suitable for more complex nucleic acid drug formulation systems. |
Streaming Potential (SP) Method | The SP method is employed to assess the potential change in a charged capillary tube by applying either pressure or an electric field, which induces liquid flow. By measuring the correlation between the flow potential and the flow electrical potential, the zeta potential can be calculated. | This method is particularly suitable for analyzing nucleic acid drug formulations across various forms and environments. |
Generally speaking, at low pH, the solvent environment contains a higher concentration of [H+] ions, resulting in particles that tend to be positively charged. Conversely, at higher pH levels, the solution has an increased concentration of [OH-] ions, leading to particles that are typically negatively charged.
Adding salt to a solution increases its ionic strength, which is influenced by both the valence and concentration of the salt. As the valence and concentration of the salt increase, the ionic strength also rises, resulting in a stronger shielding effect on the surface potential of the particles. Consequently, this leads to a decrease in the zeta potential of the particles.
If the solution environment surrounding the particles remains constant and only the concentration of the particles is altered, the zeta potential does not vary within a lower concentration range. In this range, the detected zeta potential value accurately reflects the true zeta potential. However, once the particle concentration reaches a critical threshold, the zeta potential of most systems approaches zero.
CD Formulation's Zeta potential analysis platform can be utilized to analyze various types of nanocarriers designed for encapsulating nucleic acid drugs. The variations in zeta potential among different nanocarriers in diverse environments can aid in optimizing their performance for delivering nucleic acid drugs, thereby ensuring more efficient and safer delivery to target cells or tissues in vivo.
Zeta potential analysis can demonstrate the effective drug-carrying capacity of cationic liposomes for negatively charged nucleic acid drugs, owing to their positive charge.
Zeta potential measurements enable the assessment of the surface charge density of nanoparticles and their capacity to bind nucleic acid drugs. High zeta potential values typically indicate good stability and excellent encapsulation efficiency of these nanoparticles.
Zeta potential measurements are essential for assessing the changes in surface charge of both modified and unmodified inorganic nanoparticles when encapsulating negatively charged nucleic acid drugs. The zeta potential can be tailored through surface modification to enhance biocompatibility and improve drug delivery efficiency.
CD Formulation's zeta potential analysis platform offers comprehensive zeta potential analysis services, particularly for nanocarriers coated with nucleic acid drugs.
Technology: Zeta potential analysis of optimized formulation
Journal: Pharmaceutical Development and Technology
IF: 3.4
Published: 2011
Results:
The aim of the present study was to formulate a self-emulsifying drug delivery system for atorvastatin calcium and to characterize its in vitro and in vivo potential. The prepared formulations were tested for microemulsification characteristics and evaluated for clarity, sedimentation, viscosity determination, drug content and in vitro solubility. The optimized formulations were also subjected to particle size distribution, zeta potential, stability studies and in vivo potential assessment. The in vivo performance of the optimized formulation was evaluated by using a Triton-induced hypercholesterolemia model in male albino Wistar rats. The formulation significantly reduced serum lipid levels compared to atorvastatin calcium. Thus, these studies illustrate the potential use of hydrophobic drugs such as atorvastatin calcium administered via the oral route.
Fig.2 Zeta potential analysis of optimized formulation. (Kadu P J, et al., 2011)
CD Formulation's Zeta Potential Analysis platform is equipped with state-of-the-art equipment and a dedicated team of technicians to ensure high-quality data and results. Please feel free to contact us for more information on how we can enhance your drug discovery program.
References